← Back to directory

Soumyadeep Sarkar

Researcher Next ID · RN-037202

Researcher · Earth and Planetary Sciences

Indian Institute of Technology Guwahati

Guwahati, India

Not currently recruitingFunding unknown
Works count
1,668
Citation count
385
H-index
9
i10-index
9

Research interests

Earth and Planetary Sciences
Environmental Science
Medicine
Physics and Astronomy
Ionosphere and magnetosphere dynamics
Geophysics and Gravity Measurements
Earthquake Detection and Analysis
Methane Hydrates and Related Phenomena
Pancreatic function and diabetes

Publications

  • Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells

    Diabetes · 2025 · 10.2337/db24-0527

  • Reduction of Chemokine CXCL9 Expression by Omega‐3 Fatty Acids via ADP‐Ribosylhydrolase ARH3 in MIN6 Insulin‐Producing Cells

    PROTEOMICS · 2024 · 10.1002/pmic.202400053

  • Regulation of β-cell death by ADP-ribosylhydrolase ARH3 via lipid signaling in insulitis

    Cell Communication and Signaling · 2024 · 10.1186/s12964-023-01437-1

  • Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice

    Journal of Clinical Investigation · 2024 · 10.1172/jci176136

  • Exploring new frontiers in type 1 diabetes through advanced mass-spectrometry-based molecular measurements

    Trends in Molecular Medicine · 2024 · 10.1016/j.molmed.2024.07.009

  • A fast and sensitive size‐exclusion chromatography method for plasma extracellular vesicle proteomic analysis

    PROTEOMICS · 2024 · 10.1002/pmic.202400025

  • Genetic variants in the complement system and their potential link in the aetiology of type 1 diabetes

    Diabetes/Metabolism Research and Reviews · 2023 · 10.1002/dmrr.3716

  • Analysis of a macrophage carbamylated proteome reveals a function in post-translational modification crosstalk

    Cell Communication and Signaling · 2023 · 10.1186/s12964-023-01257-3

  • Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies

    Expert Opinion on Therapeutic Targets · 2023 · 10.1080/14728222.2023.2259099

  • A proteomic meta-analysis refinement of plasma extracellular vesicles

    Scientific Data · 2023 · 10.1038/s41597-023-02748-1

  • Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes

    Cell Reports Medicine · 2023 · 10.1016/j.xcrm.2023.101261

  • Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response

    Clinical Proteomics · 2023 · 10.1186/s12014-023-09429-6

  • Frightening Fever: Familial Cold Autoinflammatory Syndrome 2 (FCAS-2) with Macrophage Activation Syndrome (MAS)

    The Indian Journal of Pediatrics · 2022 · 10.1007/s12098-022-04322-w

  • GDF15: a potential therapeutic target for type 1 diabetes

    Expert Opinion on Therapeutic Targets · 2022 · 10.1080/14728222.2022.2029410

  • Extracellular vesicles in β cell biology: Role of lipids in vesicle biogenesis, cargo, and intercellular signaling

    Molecular Metabolism · 2022 · 10.1016/j.molmet.2022.101545

  • Meta-analysis refinement of plasma extracellular vesicle composition identifies proplatelet basic protein as a signaling messenger in type 1 diabetes

    bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 10.1101/2022.09.28.509996

  • Kaposiform Hemangioendothelioma with Kasabach–Merritt Phenomenon

    The Indian Journal of Pediatrics · 2021 · 10.1007/s12098-021-03817-2

  • Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress

    Journal · 2016 · 10.20455/ros.2016.835

Current projects

    No projects listed.